Literature DB >> 15220436

Immunostimulant patch enhances immune responses to influenza virus vaccine in aged mice.

Mimi Guebre-Xabier1, Scott A Hammond, Larry R Ellingsworth, Gregory M Glenn.   

Abstract

Improvement in the immune response to influenza virus vaccination in the elderly represents the primary unmet need in influenza virus vaccination. We have shown that topical application of immunostimulating (IS) patches containing heat-labile enterotoxin of Escherichia coli (LT) enhances immune responses to injected vaccines. We extend these findings and show that LT-IS patch application enhances the antibody responses to influenza virus vaccination in both young and aged mice. LT-IS patches markedly increased influenza virus-specific immunoglobulin G (IgG), hemagglutination inhibition antibody, mucosal antibody, and T-cell responses. The magnitude of the immune responses in aged mice receiving an LT-IS patch was equivalent to or greater than that of the immune responses in young mice given vaccine alone. These results suggest that addition of an LT-IS patch may compensate for the deficient immune function seen in the aged in response to influenza virus vaccination. Therefore, use of an LT-IS patch could be a new, safe, and simple immunization strategy that may significantly improve the outcome of influenza virus vaccination in the elderly.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220436      PMCID: PMC434114          DOI: 10.1128/JVI.78.14.7610-7618.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

Review 1.  Immunity to influenza in the elderly.

Authors:  R G Webster
Journal:  Vaccine       Date:  2000-02-25       Impact factor: 3.641

2.  Effectiveness of influenza vaccination in the elderly in a community in Italy.

Authors:  E Crocetti; S Arniani; F Bordoni; G Maciocco; M Zappa; E Buiatti
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

3.  Transcutaneous immunization induces mucosal and systemic immunity: a potent method for targeting immunity to the female reproductive tract.

Authors:  C M Gockel; S Bao; K W Beagley
Journal:  Mol Immunol       Date:  2000-06       Impact factor: 4.407

4.  Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans.

Authors:  Phillip R Pittman; Gina Kim-Ahn; Dominique Y Pifat; Kevin Coonan; Paul Gibbs; Steve Little; Judith G Pace-Templeton; Robert Myers; Gerald W Parker; Arthur M Friedlander
Journal:  Vaccine       Date:  2002-01-31       Impact factor: 3.641

5.  Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination.

Authors:  I A de Bruijn; E J Remarque; C M Jol-van der Zijde; M J van Tol; R G Westendorp; D L Knook
Journal:  J Infect Dis       Date:  1999-01       Impact factor: 5.226

6.  Transcutaneous immunization: a human vaccine delivery strategy using a patch.

Authors:  G M Glenn; D N Taylor; X Li; S Frankel; A Montemarano; C R Alving
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

7.  Increased immunogenicity of the MF59-adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects.

Authors:  R Gasparini; T Pozzi; E Montomoli; E Fragapane; F Senatore; M Minutello; A Podda
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 12.434

8.  Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity.

Authors:  L Haan; W R Verweij; M Holtrop; R Brands; G J van Scharrenburg; A M Palache; E Agsteribbe; J Wilschut
Journal:  Vaccine       Date:  2001-04-06       Impact factor: 3.641

9.  Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants.

Authors:  T Scharton-Kersten; J m Yu; R Vassell; D O'Hagan; C R Alving; G M Glenn
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

10.  Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.

Authors:  Fernando Güereña-Burgueño; Eric R Hall; David N Taylor; Frederick J Cassels; Daniel A Scott; Marcia K Wolf; Zachary J Roberts; Galina V Nesterova; Carl R Alving; Gregory M Glenn
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

View more
  12 in total

Review 1.  Dysregulation of T-cell function in the elderly : scientific basis and clinical implications.

Authors:  Tamas Fulop; Anis Larbi; Anders Wikby; Eugenio Mocchegiani; Katsuiku Hirokawa; Graham Pawelec
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Immunostimulant adjuvant patch enhances humoral and cellular immune responses to DNA immunization.

Authors:  Mikayel Mkrtichyan; Anahit Ghochikyan; Nina Movsesyan; Adrine Karapetyan; Gayane Begoyan; Jianmei Yu; Gregory M Glenn; Ted M Ross; Michael G Agadjanyan; David H Cribbs
Journal:  DNA Cell Biol       Date:  2008-01       Impact factor: 3.311

3.  Topical CpG adjuvantation of a protein-based vaccine induces protective immunity to Listeria monocytogenes.

Authors:  Wing Ki Cheng; Kathleen Wee; Tobias R Kollmann; Jan P Dutz
Journal:  Clin Vaccine Immunol       Date:  2014-01-03

4.  Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: immunomodulatory effect on antigen-specific memory CD4+ T cells and impact on clinical outcome.

Authors:  D Alecsandru; L Valor; S Sánchez-Ramón; J Gil; J Carbone; J Navarro; J Rodríguez; C Rodríguez-Sainz; E Fernández-Cruz
Journal:  Clin Exp Immunol       Date:  2011-04       Impact factor: 4.330

5.  NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge.

Authors:  Natalie Pica; Ryan A Langlois; Florian Krammer; Irina Margine; Peter Palese
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

6.  Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge.

Authors:  Zhiyuan Wen; Ling Ye; Yulong Gao; Lei Pan; Ke Dong; Zhigao Bu; Richard W Compans; Chinglai Yang
Journal:  Antiviral Res       Date:  2009-09-20       Impact factor: 5.970

7.  Reduced interferon-α production by dendritic cells in type 1 diabetes does not impair immunity to influenza virus.

Authors:  D Kreuzer; E Nikoopour; B C Y Au; O Krougly; E Lee-Chan; K L Summers; S M M Haeryfar; B Singh
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

8.  Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration.

Authors:  Camila Mathias-Santos; Juliana F Rodrigues; Maria Elisabete Sbrogio-Almeida; Terry D Connell; Luís C S Ferreira
Journal:  Clin Vaccine Immunol       Date:  2011-06-15

9.  Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccines.

Authors:  Hayk Davtyan; Anahit Ghochikyan; Armine Hovakimyan; Irina Petrushina; Jianmei Yu; David Flyer; Peter Juul Madsen; Lars Ostergaard Pedersen; David H Cribbs; Michael G Agadjanyan
Journal:  J Neuroimmunol       Date:  2014-01-15       Impact factor: 3.478

10.  Dynamic changes in cellular infiltrates with repeated cutaneous vaccination: a histologic and immunophenotypic analysis.

Authors:  Jochen T Schaefer; James W Patterson; Donna H Deacon; Mark E Smolkin; Gina R Petroni; Emily M Jackson; Craig L Slingluff
Journal:  J Transl Med       Date:  2010-08-20       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.